Qingdao Vland Biotech
- Company typePublic
- Founded2005
- HeadquartersQingdao Shi, China
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Qingdao Vland Biotech firmographics
Firmographics- Name
- Qingdao Vland Biotech
- Legal name
- Qingdao Vland Biotech INC.
- Website
- https://vlandgroup.com
- Company type
- Public
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
Qingdao Vland Biotech industry classification
Industry- Product category
- Industrial Biotechnology & Animal Health
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Animal Food Manufacturing (31111), Food Manufacturing (311)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Food And Kindred Products (2000), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)
Keywords
Where Qingdao Vland Biotech is headquartered
LocationHeadquarters
- HQ city
- Qingdao Shi
- HQ country
- China
- HQ region
- Asia
Offices11 records
Markets served
Qingdao Vland Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Enzyme Preparations: Industrial enzymes for feed, textile, paper, leather, detergent industries. Includes phytase, proteases, xylanases, cellulases and specialty enzymes for various applications.
- Microecological Products: Probiotics and microbial preparations for animal health, aquaculture, plant protection, environmental remediation, and food applications. Includes Bacillus, Lactobacillus, Bifidobacterium strains.
- Animal Health Products: Veterinary vaccines (poultry, swine), veterinary pharmaceuticals, traditional Chinese veterinary medicine, and diagnostic services. Products include foot-and-mouth disease vaccines, Newcastle disease vaccines, and animal health management solutions.
- Marine & Aquaculture Products: Aquaculture nutritional products including vitamin premixes, trace mineral premixes, and specialized aquatic feeds.
- Nutritional Health: Probiotic health products for human consumption, functional foods, plant-based beverages, and seaweed enzyme products for health applications.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Qingdao Vland Biotech product offering
Product offeringCore offering
Qingdao Vland Biotech develops, manufactures, and sells enzyme preparations, microecological (probiotic) products, animal health products (vaccines and pharmaceuticals), and nutrition/health products. The company serves feed mills, livestock and aquaculture farms, food processors, and industrial manufacturers across textile, paper, leather, and detergent industries through four proprietary protein expression systems and high-throughput screening platforms.
Product overview
Qingdao Vland Biotech (蔚蓝生物) is a biotechnology company with four core business segments: Enzymes (酶制剂), Probiotics/Microecologics (微生态), Animal Health (动物保健), and Nutrition & Health (营养健康). The company offers a comprehensive portfolio including feed enzymes, industrial enzymes, and food enzymes under the enzyme segment; animal, plant, and environmental microecologics under probiotics; vaccines, veterinary pharmaceuticals, and traditional Chinese veterinary medicines under animal health; and probiotic consumer products, functional foods, and seaweed products under nutrition and health. The products serve industries including agriculture, food processing, textiles, paper manufacturing, leather, detergents, environmental protection, and human health.
Differentiator
Problem solved
Functional benefit
Brands
- VLAND疫苗 (Vland Vaccine): Brand for animal vaccines covering pig, poultry, and aquaculture diseases including classical swine fever, pseudorabies, PCV2, TGE/PED, Newcastle disease, and avian influenza vaccines.
- 蔚蓝生物技术创新共享年会 (Vland Tech Innovation Sharing Annual Conference)
- 康地恩 (KDN)
- 蔚蓝赛德 (Vland Saide)
- 蔚蓝植物微生态 (Vland Plant Microecology)
- 蔚蓝动物微生态 (Vland Animal Microecology)
- 青岛玛斯特 (Qingdao Master)
- 益家美 (Yijia Mei)
- 蔚蓝渊源有自共享实验室 (Vland Yuanyan Youzi Shared Laboratory)
- VLAND-PCP (Vland Precision Customization Platform)
Products and services
- Enzyme Preparations (酶制剂)
Quantifiable outcome
- Phytic acid enzyme reduces phosphorus excretion by 30-60%
- +2 more outcomes
Companies that use Qingdao Vland Biotech
Customer profileNamed customers6 records
Segments7 records
Ideal customer profiles4 records
Qingdao Vland Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Qingdao Vland Biotech partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered major, core and minor.
- Qingdao Synthetic Biology Technology Innovation Strategic AlliancemajorLed by Qingdao Science and Technology Bureau, with CAS Qingdao Institute of Bioenergy and other enterprises. Focuses on synthetic biology technology research and industry development.
- Westmill Foods Group (西麦食品)majorStrategic cooperation for oat food R&D and health product development. Joint development of barley-based functional foods and probiotic products for Chinese market.
- ADM-Vland Biotechnology (艾地盟蔚蓝生物科技)coreJoint venture for food probiotic products manufacturing and sales. Products target global market through ADM's distribution network.
- Evonik-Vland Biotechnology (赢创蔚蓝生物科技)coreJoint venture established for animal nutrition probiotic products. Combines Evonik's gut health expertise with Vland's manufacturing capabilities for global market.
- Jiangsu Academy of Agricultural Sciences (江苏省农业科学院)majorStrategic cooperation for feed nutrition, animal health, and future food technology. Joint research projects, commissioned R&D, and technology transfer.
- Beijing Dingchi Biotechnology (北京鼎持生物技术有限公司)majorJoint development of novel poultry vaccines using cell suspension culture technology. Combined Vland's manufacturing capability with partner's technology expertise.
- Evonik Industries (赢创工业集团)coreStrategic cooperation for probiotics in animal nutrition and industrial enzymes. Includes technology exchange, joint product development, and process technology improvement for gut health solutions.
- ADM (Archer Daniels Midland)coreStrategic cooperation since 2017, initially for feed enzyme development. Expanded to joint R&D center establishment in Qingdao and US, with joint commercialization of enzyme products globally. In 2021, expanded to health food cooperation including barley products (qingke).
- China Pharmaceutical University (中国药科大学)minorAcademic cooperation for new drug development, particularly in biological enzymes and synthetic biology applications.
- Nanjing Agricultural University (南京农业大学)minorAcademic cooperation for enzyme applications, microecological products, and intestinal health research.
Scale indicators12 records
Recent moves10 records
Expansion highlights6 records
Qingdao Vland Biotech competitors and assessment
Company assessmentDirect peers
- Zoetis: World's largest animal health company, dominant in livestock and companion animal vaccines and pharmaceuticals. Most relevant global benchmark for Vland's animal vaccine portfolio (PCV2, TGE/PED, Newcastle, classical swine fever).
- Lallemand Animal Nutrition: Specialist in yeast, bacteria, and fungal probiotics for animal feed and silage. Direct competitor to Vland's Bacillus, Lactobacillus, and Bifidobacterium-based animal microecology products.
- Angel Yeast: Largest Chinese yeast and enzyme manufacturer with comparable product mix spanning baker's yeast, animal-feed yeast, and industrial enzymes. Strongest domestic Chinese competitor to Vland's enzyme segment.
- Jinyu Biotechnology (金宇生物技术): Leading Chinese veterinary vaccine manufacturer (foot-and-mouth disease, swine and poultry vaccines). Listed Chinese peer with strongest overlap on Vland's animal vaccine business.
- Novonesis (formerly Novozymes): Global leader in industrial and feed enzymes with a comparable protein-expression-engineered product portfolio spanning feed, food, textiles, and paper applications. Most direct competitor to Vland's enzyme preparations segment.
- Chr. Hansen (merged into Novonesis): Leading microbial and probiotic culture supplier for animal and human nutrition. Directly competes with Vland's microecology and human probiotic (Yijia Mei) segments.
- Pulike Biological Engineering (普莱柯生物): Chinese animal vaccine and diagnostic manufacturer listed on the Shanghai Stock Exchange. Competes in poultry and swine vaccines directly with Vland's VLAND Vaccine product line.
- Elanco Animal Health: Global animal health company with companion-animal and livestock pharmaceuticals and vaccines. Competes with Vland's veterinary pharmaceutical and traditional Chinese veterinary medicine segments.
- Kemin Industries: Privately held ingredient manufacturer for animal feed, pet food, and human health with comparable enzyme and probiotic offerings. Direct competitor in feed enzymes and gut-health additives.
- dsm-firmenich Animal Nutrition: Global animal nutrition premix and additive leader (post-DSM merger with Firmenich). Competes head-to-head in feed enzymes, vitamin premixes, and gut-health probiotics sold to feed mills.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Qingdao Vland Biotech social profiles
Digital presenceQingdao Vland Biotech compliance and trust
Trust signalCompliance6 records
Qingdao Vland Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qingdao Vland Biotech leadership team
Management profileNumber of profiles
Profiles11 records
Qingdao Vland Biotech subsidiaries and ownership
Company hierarchySubsidiaries19 records
Qingdao Vland Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qingdao Vland Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qingdao Vland Biotech
What does Qingdao Vland Biotech do?
Qingdao Vland Biotech develops, manufactures, and sells enzyme preparations, microecological (probiotic) products, animal health products (vaccines and pharmaceuticals), and nutrition/health products. The company serves feed mills, livestock and aquaculture farms, food processors, and industrial manufacturers across textile, paper, leather, and detergent industries through four proprietary protein expression systems and high-throughput screening platforms.
Is Qingdao Vland Biotech a public or private company?
Qingdao Vland Biotech is a public company. It is classified as public and is currently operating.
When was Qingdao Vland Biotech founded?
Qingdao Vland Biotech was founded in 2005. It employs 5,001 to 10,000 people.
Where is Qingdao Vland Biotech based?
Qingdao Vland Biotech is headquartered in Qingdao Shi, China, in the Asia region.
How does Qingdao Vland Biotech make money?
Five revenue lines are on record. Enzyme Preparations are the primary driver. The others are microecological Products, animal Health Products, marine & Aquaculture Products and nutritional Health.
Who are Qingdao Vland Biotech's main competitors?
Direct peers on record are Zoetis, Lallemand Animal Nutrition, Angel Yeast, Jinyu Biotechnology (金宇生物技术), Novonesis (formerly Novozymes), Chr. Hansen (merged into Novonesis), Pulike Biological Engineering (普莱柯生物), Elanco Animal Health, Kemin Industries and dsm-firmenich Animal Nutrition.
Does Qingdao Vland Biotech have an API?
No public API is recorded for Qingdao Vland Biotech.
What industry is Qingdao Vland Biotech in?
Qingdao Vland Biotech's product category is Industrial Biotechnology & Animal Health. Its primary akta.pro industry code is HLAMAHAH, Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2836.